A new pill could reduce the spread of STDs
Find out all the details about the antibiotic DoxyPEP that reduces the probability of contracting STDs when having unprotected sex!

Publicado el 03/10/2023 a las 13:54
- There’s a new pill to prevent STDs.
- Health authorities are looking for alternatives to condoms.
- DoxyPEP could be the answer.
Public health officials in the United States are reportedly considering using a common antibiotic that works as a morning-after pill to combat sexually transmitted diseases.
The Washington Post reported that the Centers for Disease Control and Prevention will soon release guidelines for the treatment.
It is known as DoxyPEP, and it aims to reduce the spread of STDs.
What is DoxyPEP?

DoxyPEP is a post-exposure preventive treatment for syphilis, chlamydia and gonorrhea.
This is according to information from the CDC.
This common antibiotic can function like a morning-after pill.
It reduces the risk of contracting an STD after unprotected sexual encounters.
Concerns arise over the medicine’s side effects

Health experts expressed concerns about the unintended consequences that may arise from taking DoxyPEP.
This antibiotic aims to counter the risk of contracting an STD after unprotected sex.
The Washington Post reported that the preventive use of DoxyPEP could promote antibiotic resistance.
This could also contribute to the emergence of drug-resistant superbugs.
DoxyPEP could be a historic advancement for STDs and science

Health experts told The Washington Post that the efficacy of DoxyPEP for STDs is a significant advancement in the history of science.
Jonathan Mermin, who leads STD prevention for the CDC, said: «It’s the first major intervention we’ve had for STIs since the vaccine for human papillomavirus.»
The HPV vaccine came out nearly two decades ago.
The treatment is currently available to a small group

Some doctors have already begun prescribing the DoxyPEP treatment to a small segment of the gay community.
This community is considered to have a higher risk of contracting an STD.
According to Jorge Roman from the San Francisco AIDS Foundation, «Just like PrEP was a game-changer, this allows people to make decisions about their sexual health.»
The San Francisco AIDS Foundation was one of the first centers to widely distribute the antibiotic.

